Numinus (TSX:NUMI): A psychedelic stock to explore amid 'shroom boom'?

January 13, 2022 09:47 AM EST | By Kajal Jain
Follow us on Google News:

Highlights

  • Stocks of Numinus Wellness Inc (TSX: NUMI) have been noting an uptick as the psychedelic-centered healthcare company nears the release of its Q1 FY2022 results this month.
  • NUMI stock gained by over 13 per cent on Wednesday, January 12, recording a trading volume of 1.5 million.
  • Numinus recently rescheduled the release date for its first quarter results of FY2022 from January 13 to January 20 due to staffing challenges posed by the coronavirus pandemic.

Stocks of Numinus Wellness Inc (TSX: NUMI) have been noting an uptick as the psychedelic-centered healthcare company nears the release of its Q1 FY2022 results this month.

NUMI stock gained by over 13 per cent on Wednesday, January 12, recording a trading volume of 1.5 million.

Numinus recently rescheduled the release date for its first quarter results of FY2022 from January 13 to January 20 due to staffing challenges posed by the coronavirus pandemic.

The Vancouver, British Columbia-headquartered healthcare firm is engaged in the research and development of therapeutic solutions based on psychedelic medications. The healthcare provider operates wellness clinics and laboratories to produce mental healthcare products and provide related healthcare services.

Let us have a closeer look at the financial and stock performances of Numinus Wellness.

Numinus Wellness Inc (TSX: NUMI) stock performance

Stocks of Numinus Wellness fell by roughly 36 per cent in the past year. However, the psychedelic stock has rocketed by over 43 per cent in 2022.

NUMI stock also surged by over 38 per cent in the last one week.

On Tuesday, the mental healthcare firm saw its stock close at C$ 0.76 apiece.

Numinus Wellness Inc (TSX: NUMI) stock performance

 Image source: © 2022 Kalkine Media®    

Also read: Is Cielo Waste (TSXV:CMC) a cheap stock to buy?  

Numinus Wellness Inc’s financial performance in Q4 FY2021

Numinus Wellness saw a revenue of C$ 0.5 million in the fourth quarter of fiscal 2021. The topline generated in the latest quarter denoted a year-over-year (YoY) increment of 81.1 per cent, which it said was mainly due to the acquisition of Montreal-based psychology clinic Mindspace Wellbeing.

The Canadian healthcare company recorded a gross profit of C$ 0.031 million in the latest quarter, which was up from a gross loss of C$ 0.158 million incurred a year ago.

Numinus Wellness also reported a loss of C$ 7.8 million in Q4 FY2021, which included a non-cash goodwill impairment charge of C$ 1.6 million due to the acquisition of Mindspace Wellbeing.

Also read: Are these unique ocean energy stocks under $6 too cheap to ignore?

Bottomline

During Q4 FY2021, the Health Canada-approved psychedelic-focused wellness company also started expanding its psychedelic research facility, including an additional laboratory. 

On December 22 last year, Health Canada revised its Special Access Programme, wherein physicians were allowed to request psychedelic medicines. This amendment can be see Numinus Wellness accelerate its business footprints further.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.



Top TSX Listed Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK